 |
 |

Human Immunodeficiency Virus Prophylaxis for Sexual Assault Survivors
What We Need to Know
Arch Pediatr Adolesc Med. 2006;160:754-755.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
A dolescent sexual assault is unfortunately all too common. An analysis of the 2001 Youth Risk Behavior Survey revealed that 10.2% of women and 5.1% of men reported forced sexual intercourse at least once in their lifetimes.1 Recent National Criminal Victimization Survey results revealed that annually 1/10 of one percent of all individuals aged 12 or older had survived rape or sexual assault.2 The ratio of male-female survivors is 1:10, and 29% of victims are 12 to 17 years old.
There is a general concern that survivors are at increased risk for acquiring human immunodeficiency virus (HIV) infection via the sexual assaults. Most reviews cite a case report by Murphy et al,3 which describes HIV seroconversion related to rape. Epidemiological studies of consensual coitus have shown that the risk for heterosexual sexual transmission from 1 coital act ranges from 0.001 to 0.008.4 Estimates vary by the stage of the infected . . . [Full Text of this Article] AUTHOR INFORMATION
Jonathan M. Ellen, MD
RELATED ARTICLE
Use of Human Immunodeficiency Virus Postexposure Prophylaxis in Adolescent Sexual Assault Victims
Elyse Olshen, Katherine Hsu, Elizabeth R. Woods, Marvin Harper, Brooke Harnisch, and Cathryn L. Samples
Arch Pediatr Adolesc Med. 2006;160(7):674-680.
ABSTRACT
| FULL TEXT
|